iifl-logo

Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF

Fund Name

:  Nippon India Mutual Fund

Scheme Name

:  Nippon India Nifty Pharma ETF

AMC

:  Nippon India Mutual Fund

Type

:  Open

Category

:  Exchange Traded Funds (ETFs)

Launch Date

:  21-Jun-2021

Fund Manager

:  Jitendra Tolani

Net Assets (Rs. cr)

:  1756.56

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Nippon India Nifty Pharma ETF - Nav Details

Nav Date

:  19-Nov-2026

NAV [Rs.]

:  29.1708

Buy/Resale Price [Rs.]

:  0

Sell/Repurchase Price [Rs.]

:  0

Entry Load %

:  Nil

Exit Load %

:  Nil

Nippon India Nifty Pharma ETF- NAV Chart

Nippon India Nifty Pharma ETF- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-1.06
10.76
7.79
14.36
25.28
21.97
16.6
14.01
Category Avg
-0.76
5.48
-0.17
2.94
1.34
12.99
10.49
9.76
Category Best
4.88
17.7
13.97
23.16
32.02
30.28
28.85
114.62
Category Worst
-10.96
-22.62
-29.66
-40
-31.63
-1.36
-1.31
-38.19

Nippon India Nifty Pharma ETF- Latest Dividends

No Records Found

Nippon India Nifty Pharma ETF- Investment Details

Min. Investment(Rs.)

:  1000

Increm.Investment(Rs.)

:  0

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology18.611838507326.83
EquityDivi's Lab.Pharmaceuticals & Biotechnology12.28220594215.74
EquityLaurus LabsPharmaceuticals & Biotechnology9.26676210162.66
EquityDr Reddy's LabsPharmaceuticals & Biotechnology8.151058934143.16
EquityCiplaPharmaceuticals & Biotechnology7.67977187134.74
EquityTorrent Pharma.Pharmaceuticals & Biotechnology6.71255564117.90
EquityLupinPharmaceuticals & Biotechnology4.8342179984.82
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.5947988680.68
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology3.4226144760.09
EquityZydus Lifesci.Pharmaceuticals & Biotechnology3.0543030153.59
EquityAlkem LabPharmaceuticals & Biotechnology3.0510475353.56
EquityMankind PharmaPharmaceuticals & Biotechnology2.7919681849.06
EquityIpca Labs.Pharmaceuticals & Biotechnology2.6524119946.49
EquityGland PharmaPharmaceuticals & Biotechnology2.4413828642.81
EquityBioconPharmaceuticals & Biotechnology2.42121013942.57
EquitySai LifePharmaceuticals & Biotechnology2.1324011937.39
EquityAjanta PharmaPharmaceuticals & Biotechnology1.587924827.80
EquityWockhardtPharmaceuticals & Biotechnology1.5514344527.27
EquityPiramal PharmaPharmaceuticals & Biotechnology1.47107865625.77
EquityAbbott IndiaPharmaceuticals & Biotechnology1.32905823.22

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
8,03,520.11
Trustee/s:
NA
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
NA

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.